Morgan Stanley Sera Prognostics, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 82,327 shares of SERA stock, worth $228,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares

82,327

Previous 181,472 54.63%

Holding current value

$228,045

Previous $1.57 Million 80.8%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$3.54 - $8.33 $350,973 - $825,877	-99,145 Reduced 54.63%	82,327 $302,000
Q4 2024 Feb 14, 2025	SELL	$6.03 - $8.83 $260,278 - $381,138	-43,164 Reduced 19.22%	181,472 $1.57 Million
Q3 2024 May 14, 2025	SELL	$5.29 - $8.43 $129,425 - $206,248	-24,466 Reduced 9.82%	224,636 $1.75 Million
Q3 2024 Nov 14, 2024	SELL	$5.29 - $8.43 $129,425 - $206,248	-24,466 Reduced 9.82%	224,636 $1.75 Million
Q2 2024 May 14, 2025	BUY	$5.6 - $11.69 $378,728 - $790,594	67,630 Added 37.27%	249,102 $1.47 Million
Q2 2024 Oct 17, 2024	BUY	$5.6 - $11.69 $521,163 - $1.09 Million	93,065 Added 59.64%	249,102 $1.47 Million
Q2 2024 Aug 14, 2024	BUY	$5.6 - $11.69 $521,163 - $1.09 Million	93,065 Added 59.64%	249,102 $1.47 Million
Q1 2024 Oct 17, 2024	SELL	$5.05 - $10.0 $469,978 - $930,650	-93,065 Reduced 37.36%	156,037 $1.42 Million
Q1 2024 Aug 16, 2024	BUY	$5.05 - $10.0 $652,712 - $1.29 Million	129,250 Added 482.51%	156,037 $1.42 Million
Q1 2024 May 15, 2024	BUY	$5.05 - $10.0 $652,712 - $1.29 Million	129,250 Added 482.51%	156,037 $1.42 Million
Q4 2023 Aug 16, 2024	SELL	$1.65 - $6.85 $366,819 - $1.52 Million	-222,315 Reduced 89.25%	26,787 $160,000
Q4 2023 Feb 13, 2024	BUY	$1.65 - $6.85 $37,567 - $155,960	22,768 Added 566.51%	26,787 $160,000
Q3 2023 Nov 15, 2023	BUY	$1.55 - $3.34 $387 - $835	250 Added 6.63%	4,019 $7,000
Q2 2023 Aug 14, 2023	SELL	$3.0 - $3.98 $5,424 - $7,195	-1,808 Reduced 32.42%	3,769 $12,000
Q1 2023 May 15, 2023	BUY	$1.19 - $4.25 $2,840 - $10,144	2,387 Added 74.83%	5,577 $21,000
Q4 2022 Feb 14, 2023	SELL	$1.16 - $1.8 $8,187 - $12,704	-7,058 Reduced 68.87%	3,190 $4,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $2.71 $1,067 - $1,867	689 Added 7.21%	10,248 $17,000
Q2 2022 Oct 27, 2022	BUY	$1.2 - $3.62 $322 - $973	269 Added 2.9%	9,559 $16,000
Q2 2022 Aug 15, 2022	BUY	$1.2 - $3.62 $322 - $973	269 Added 2.9%	9,559 $16,000
Q1 2022 Oct 27, 2022	SELL	$2.96 - $8.8 $796 - $2,367	-269 Reduced 2.81%	9,290 $35,000
Q1 2022 May 13, 2022	BUY	$2.96 - $8.8 $8,850 - $26,312	2,990 Added 47.46%	9,290 $35,000
Q4 2021 Feb 14, 2022	BUY	$6.87 - $11.41 $41,529 - $68,973	6,045 Added 2370.59%	6,300 $44,000
Q3 2021 Nov 15, 2021	BUY	$7.9 - $13.04 $2,014 - $3,325	255 New	255 $3,000

Others Institutions Holding SERA

# of Institutions

Shares Held

22.7M

Call Options Held

300

Put Options Held

800

View Full List

About SERA PROGNOSTICS, INC.

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $82M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

More about SERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account